Webbasx 200 7,219.000-18.200 -0.25% s&p/asx 100 6,056.200-11.400 -0.19% s&p/asx 50 7,083.100-6.300 -0.09% 豪州市場 銘柄情報 RHY Rhythm Biosciences Ltd 銘柄追加 Webb10 apr. 2024 · This page (ASX:RHY) was last updated on 4/10/2024 by MarketBeat.com Staff. Get 30 Days of MarketBeat All Access Free. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring.
Rose Above Upper Bollinger Band today: $QVE $MAF $RHY
Webb11 apr. 2024 · if RHY are still pursuing events like this. I’d hate to think what their ‘commercial discussions’ at ‘different levels’ have really amounted to. It’d be great to see something material eventuate. Webb7 apr. 2024 · Rhythm Biosciences Limited (ASX: RHY) - Share Price and Research - Current share price for RHY : $0.485 Rhythm Biosciences Limited (RHY), an ASX-listed company, is involved in developing and commercialising Australian medical diagnostics technology for sale in domestic and international markets. phineas thomas
RHY (ASX) Ann: ColoSTAT abstracts accepted at 2024 ASCO …
Webb16 mars 2024 · Rhythm Biosciences (ASX:RHY) has a market capitalization of $0.00 and … Webb21 mars 2024 · ASX:RHY Rhythm Biosciences - RHY News Today Compare Today's Range N/A 50-Day Range N/A 52-Week Range N/A Volume N/A Average Volume N/A Market Capitalization N/A P/E Ratio N/A Dividend Yield N/A Price Target N/A Profile Chart Competitors Insider Trades Get Rhythm Biosciences News Delivered to You Automatically Webb4 apr. 2024 · Rhythm Biosciences releases positive results of ColoSTAT MedAdvisor’s acquisition Adheris exceeds revenue target In a major development today, Rhythm Biosciences (ASX:RHY) was up 15% after announcing that its blood test product ColoSTAT exhibited very high accuracy for the detection of colorectal cancer. phineas to germany google translate